EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study

Mariëlle M C van der Hoorn, Gerard A Kalkman iD, Yvette M Weesie, Femke Atsma, Arnt Schellekens

BJPsych Open · 2023-05 · 9 (3)

DOI: 10.1192/bjo.2023.54 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJPsych Open, online erschienen am 20.04.2023. Verfasst von Mariëlle M C van der Hoorn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands; and Department of Psychiatry, Radboud University Medical Center,…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic high-dose (CHD) prescription opioid use is a major public health concern. Although CHD opioid use has been associated with psychiatric disorders, the causality could go both ways. Some studies have already linked psychiatric disorders to an increased risk of transitioning to chronic opioid use, and longitudinal data identifying psychiatric disorders as predictors of CHD opioid use could shed further light on this issue.

Aims

To prospectively examine the relationship between the presence of a psychiatric disorder and subsequent development of CHD opioid use in primary care patients newly receiving opioids.

Method

Data were included from 137 778 primary care patients in The Netherlands. Cox regression modelling was used to examine the association between psychiatric disorders prior to a new opioid prescription and subsequent CHD opioid use (≥90 days; ≥50 mg/day oral morphine equivalents) in the subsequent 2 years.

Results

Of all patients receiving a new opioid prescription, 2.0% developed CHD opioid use. A psychiatric disorder before the start of an opioid prescription increased the risk of CHD opioid use (adjusted hazard ratio HR = 1.74; 95% CI 1.62–1.88), specifically psychotic disorders, substance use disorders, neurocognitive disorders and multiple co-occurring psychiatric episodes. Similarly, pharmacotherapy for psychosis, substance use disorders and mood and/or anxiety disorders increased the risk of CHD opioid use. Psychiatric polypharmacy conferred the greatest risk of developing CHD opioid use.

Conclusions

Psychiatric disorders increase the risk of developing CHD opioid use in patients newly receiving prescription opioids. To reduce the public health burden of CHD opioid use, careful monitoring and optimal treatment of psychiatric conditions are advised when opioid therapy is initiated.

Schlagwörter

Stichwörter der Autor:innen

Primary caredrugs of dependence disordersopiate disorderspain carerisk assessment

Autor:innen und Institutionen

  • Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands; and Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Clinical Pharmacy, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands; and Radboud Institute for Health Sciences, Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen…
  • Netherlands Institute for Health Services Research, Nivel, Utrecht, The Netherlands.
  • Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands; Nijmegen Institute for Scientist-Practitioners in Addiction, Radboud University, Nijmegen, The Netherlands; and Donders Institute f…

ORCID-Profile: Gerard A Kalkman

Zitieren

APA

van der Hoorn, M. M. C., Kalkman, G. A., Weesie, Y. M., Atsma, F., & Schellekens, A. (2023). Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study. BJPsych Open, 9(3). https://doi.org/10.1192/bjo.2023.54

Vancouver

van der Hoorn MMC, Kalkman GA, Weesie YM, Atsma F, Schellekens A. Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study. BJPsych Open. 2023;9(3). doi:10.1192/bjo.2023.54

BibTeX
@article{vanderHoorn2023,
  author = {van der Hoorn, Mariëlle M C and Kalkman, Gerard A and Weesie, Yvette M and Atsma, Femke and Schellekens, Arnt},
  title = {Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study},
  journal = {BJPsych Open},
  year = {2023},
  volume = {9},
  number = {3},
  doi = {10.1192/bjo.2023.54}
}
Kostenlos starten →